Niranjan Bose
@niranjanbose
Followers
2K
Following
1K
Media
60
Statuses
3K
Managing Director at Gates Ventures. Microbiologist turned strategy consultant turned generalist leader driving change! My own neurons fire up my tweets.
Seattle, WA
Joined April 2009
Supercharging Alzheimer’s Research: Gates Ventures Backs a Million-Dolla... https://t.co/kINobJawpo via @YouTube
1
0
3
What a fantastic day for the beautiful game! @SoundersFC vs Inter Miami featuring the GOAT. Let’s go Sounders and let’s go Messi!
1
0
7
New USD 1 million prize competition aims to revolutionize Alzheimer's research by leveraging agentic AI systems backed by Bill Gates https://t.co/SImeRJPqDK via @ETHealthWorld
health.economictimes.indiatimes.com
The Alzheimer's Disease Data Initiative announces a groundbreaking $1 million competition for innovative AI solutions to enhance Alzheimer's research, supported by Bill Gates and a coalition of...
0
0
4
The AI Alzheimer’s prize is the latest effort to deploy the promising technology to find cures for humanity’s toughest illnesses. https://t.co/nj8dESNWdZ
81
110
387
I'm proud to share that applications are now open for the $1 million Alzheimer’s Insights AI Prize for ADRD research – a global competition to find new, AI-driven solutions to speed up our fight against Alzheimer's disease. @AlzData Apply here: https://t.co/YrrWU2Edhe
0
4
9
With 40,000 blood and CSF samples, the GNPC’s neurodegeneration proteomics dataset is the largest disease-specific effort yet. #alzheimersdisease @_neuroproteome
0
6
20
The USC Clinical Trial Recruitment Lab calls for more inclusive, equitable access to Alzheimer’s clinical trials in a new @journal_ad paper—featuring insights from leaders across the field, including ADDF Board Members @niranjanbose and @PhylFerrell. https://t.co/lnJmpjZIt9
0
3
5
Let’s break this record #Seattle @SoundersFC We are coming for you San Jose! @GWR welcome to Seattle!
1
0
0
ADDF’s Diagnostics Accelerator (DxA) published a paper in Alzheimer’s & Dementia providing a landscape review of blood & ocular biomarkers presenting the opportunity to identify at-risk individuals who may otherwise go undiagnosed. @niranjanbose
https://t.co/WrYnCCFfrC
0
1
0
Q&A: BCG on the US healthcare system and the use of AI https://t.co/lXbl8ZmHw6 via @MobiHealthNews good to see a consulting firm provide their perspective.... are there solutions to propose as well? There are some clues in the interview but not called out explicitly.
0
0
1
@AlzData The integration of the @imi_epnd Hub and the AD Workbench provides more opportunities for researchers to collaborate, share, access and analyse data to further our shared goal of accelerating discoveries in neurodegenerative disease research @niranjanbose
https://t.co/pJXYbAfu6G
epnd.org
Today, we are excited to launch the EPND Hub, a major expansion of our data and biosample catalogue that offers new capabilities and enhanced interoperability.
1
1
3
Agree, @Atul_Gawande. Global health investments have transformed economies and extended life expectancies but continuing that progress will require greater global leadership and collaboration, especially in an era of divided trust in public health institutions.
In a conversation with @TomBollyky, @Atul_Gawande emphasizes that investing in global health will strengthen alliances and security in an age when many threats transcend borders. @allisonkrugman elaborates: https://t.co/WbqA99LlsU
0
3
6
Integrated data sharing platforms to accelerate research into ALS and Alzheimer’s disease
nrtimes.co.uk
Research consortium, Answer ALS, and the Alzheimer’s Disease Data Initiative (AD Data Initiative), are embarking on a partnership to integrate the AD Data Initiative’s AD Workbench with Answer ALS’s...
1
0
1